The 43 references in paper A. Shishkin N., N. Hudiakova V., N. Temnaja V., А. Шишкин Н., Н. Худякова В., Н. Темная В. (2014) “Микроальбуминурия при метаболических нарушениях у женщин в перименопаузе // Microalbuminuria and metabolic disorders in perimenopausal women” / spz:neicon:nefr:y:2014:i:1:p:62-67

1
Ford ES. The metabolic syndrome and mortality from cardiovascular disease and all-causes: Findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 2004 (173): 309–314
(check this in PDF content)
2
Wang. Z, Wang FF, Zhu XJ et al. Metabolic syndrome and microalbuminuria accompanied with hyperglycemia in community subjects. Zhonghua Yi Xue Za Zhi 2012 Sep 25; 92(36): 2526-2529
(check this in PDF content)
3
El Azeem HA, Khalek el-SA, El-Akabawy H et al. Association between nonalcoholic fatty liver disease and the incidence of cardiovascular and renal events. J Saudi Heart Assoc 2013 Oct; 25 (4): 239-246
(check this in PDF content)
4
Michalakis K, Mintziori G, Kaprara A et al. The complex interaction between obesity, metabolic syndrome and reproductive axis: a narrative review. Metabolism 2013 Apr; 62 (4): 457-478
(check this in PDF content)
5
Иванов НВ, Сильницкий ПА, Ворохобина НВ. Нарушения репродуктивной функции у мужчин с метаболическим синдромом. Балтийский журнал современной эндокринологии 2011; (2): 98-105
(check this in PDF content)
6
Singh AK, Kari JA. Metabolic syndrome and chronic kidney disease. Curr Opin Nephrol Hypertens 2013 Mar; 22(2): 198-203
(check this in PDF content)
7
Chen J, Muntner P, Hamm LL et al. The metabolic syndrome and chronic kidney disease in U. S. adults. Ann Intern Med 2004;140 (3): 167–174
(check this in PDF content)
8
Ryu S, Chang Y, Woo HY et al. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes. Am J Kidney Dis 2009; 53(1): 59-69
(check this in PDF content)
9
Yang T, Chu CH, Hsu CH et al. Impact of metabolic syndrome on the incidence of chronic kidney disease: a Chinese cohort study. Nephrology (Carlton) 2012;17(6):532-538
(check this in PDF content)
10
Пчелин ИЮ, Шишкин АН, Лаптева ОА. Роль системного и локального воспаления в развитии диабетической нефропатии. Нефрология 2011; 15 (4): 21-26
(check this in PDF content)
11
Alberti КG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; (15): 539-553
(check this in PDF content)
12
Scott M, Grundy MD, Becker D et al. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of Hight Blood Cholesterolin Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of hight blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002 (106): 3143-3421
(check this in PDF content)
13
Jarraya F, Lakhdar R, Kammoun K et al. Microalbuminuria A Useful Marker of Cardiovascular Disease. Iranian Journal of Kidney Diseases 2013 May;7 (3):178-186
(check this in PDF content)
14
Aaron R. Folsom. Classical and Novel Biomarkers for Cardiovascular Risk Prediction in the United States. J Epidemiol 2013; 23(3):158-162.
(check this in PDF content)
15
Добронравов ВА, Смирнов АВ, Каюков ИГ. Многогранная микроальбуминурия: аспекты клинического значения. Нефрология 2009; 13 (3); 33-38
(check this in PDF content)
16
ишкин АН, Худякова НВ, Смирнов ВВ. Менопаузальный метаболический синдром. Современные представления. Вестн С.-Петерб ун-та 2013; 11 (2): 17–27
(check this in PDF content)
17
Spenser CP, Godsland IF, Stevenson C. Is there a menopause metabolic syndrome? Gynecol Endocrinol 1997; (11): 341345
(check this in PDF content)
18
Скибицкий ВВ, Шухардина ЕЛ, Медведева ЮН, Кармазина В.В. Взаимосвязь ремоделирования левого желудочка с гемодинамическими и метаболическими факторами у женщин с артериальной гипертонией в ранней постменопаузе. ЮжноРоссийский медицинский журн 2004; (3):16-19
(check this in PDF content)
19
Troy BL, Pombo J, Rackley CE. Measurement of left ventricular wall thickness and mass by echocardiography.Circulation 1972;45:602–11
(check this in PDF content)
20
Lang RM, Bierig M, Devereux RB, Flachskampf FA et al. Recommendations for chamber quantification: A report from the American Society of echocardiography’s Guidelines and Standards committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of echocardiography, a branch of the European Society of cardiology. J Am Soc Echocardiogr 2005;18:1440–1463
(check this in PDF content)
21
DuBois D, DuBois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916;17:863–871
(check this in PDF content)
22
Gеnau A, Devereux RB, Roman MJ. Pattern left ventricular hypertrophy and geometric remodeling in essential hypertension. J Amer Coll Cardiol 1992; 19Е: 1550-1558
(check this in PDF content)
23
Alberti КG, Eckel RH, Grundy SM et al. Harmonizing the metabolic syndrome. Circulation 2009; 120 (16): 1640-1645
(check this in PDF content)
24
Eiamthanasinchai S, Laowahutanont N, Yamwong P., Teerapornlertratt T. Prevalence and factors associated with microalbuminuria and abnormal renal function in Thai obese adults. J Med Assoc Thai 2013;96 (2):9-16
(check this in PDF content)
25
Dutta D, Choudhuri S, Mondal SA et al. Urinary albumincreatinine ratio predicts prediabetes progression to diabetes and reversal to normoglycemia: Role of associated insulin resistance, inflammatory cytokines and low vitamin-D. J Diabetes 2013 20. doi: 10.1111/1753-0407.12112. [Epub ahead of print]
(check this in PDF content)
26
Navarro-González JF, Mora C, Muros M et al. Association of tumor necrosis factor-alpha with early target organ damage in newly diagnosed patients with essential hypertension. J Hypertens 2008; 26(11):2168-2175
(check this in PDF content)
27
Chen F, Wang J, Liu X et al. Levels of Inflammatory Cytokines in Type 2 Diabetes Patients with Different Urinary Albumin Excretion Rates and Their Correlation with Clinical Variables. Journal of Diabetes Research 2013 Oct: 1-6
(check this in PDF content)
28
Moura RSSS, Vasconcelos DF, Freitas E et.al. Cystatin C, CRP, Log TG/HDLc and Metabolic Syndrome are Associated with Microalbuminuria in Hypertension. Arq Bras Cardiol 2013; [online].ahead print: 0-0
(check this in PDF content)
29
Rodilla E, Costa JA, Martín J et al. Impact of abdominal obesity and ambulatory blood pressure in the diagnosis of left ventricular hypertrophy in never treated hypertensives. Med Clin (Barc).2 013 Oct (16) [online].ahead print: 0-0
(check this in PDF content)
30
Naidoo DP. The link between microalbuminuria, endothelial dysfunction and cardiovascular disease in diabetes. Cardiovasc J S Afr 2002 Jul-Aug;13(4):194-199
(check this in PDF content)
31
Sjöblom P, Nystrom FH, Länne T. et al. Microalbuminuria, but not reduced eGFR, is associated with cardiovascular subclinical organ damage in type 2diabetes. J Diabetes Metab 2013 Nov 4. (13)[online].ahead print: 0-0
(check this in PDF content)
32
Wolfgang L, Bjoern M, Stritzke J et al. Association of lowgrade urinary albumin excretion with left ventricular hypertrophy in the general population: The MONICA/KORA Augsburg Echocardiographic Substudy. NDT 2006; 21 (10): 2780–2787
(check this in PDF content)
33
Нечесова ТА, Коробко ИЮ, Кузнецова НИ. Ремоделирование левого желудочка: патогенез и методы оценки. Медицинские новости 2008; (11): 7-13
(check this in PDF content)
34
Cuspidi C, Giudici V, Negri F. et al. Left ventricular geometry, ambulatory blood pressure and extra-cardiac organ damage in untreated essential hypertension. Blood Press Monit 2010 Jun;15(3):124-131
(check this in PDF content)
35
Mattu HS, Randeva HS. Role of adipokines in cardiovascular disease. Journal of endocrinology 2013 (216): 17-36
(check this in PDF content)
36
Kong ХL, Jia XY, Wei Y et al. Association between microalbuminuria and subclinical atherosclerosis evaluated by carotid artery intima-media in elderly patients with normal renal function. BMC Nephrology 2012; http:// www.biomedcentral.com/14712369/13/37
(check this in PDF content)
37
Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010 (72): 219-246
(check this in PDF content)
38
López-Andrés N, Rousseau A, Akhtar R et al. Cardiotrophin 1 Is Involved in Cardiac, Vascular, and Renal Fibrosis and Dysfunction. Hypertension 2012; (60): 563-573
(check this in PDF content)
39
Piya MK, McTernan PG, Kumar S. Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin. J. of endocrinology 2013; (216): 1-15
(check this in PDF content)
40
Elseweidy MM, Elswefy SE, Younis NN et al. Pyridoxamine, an inhibitor of protein glycation, in relation to microalbuminuria and proinflammatory cytokines in experimental diabetic nephropathy. Exp Biol Med (Maywood) 2013 Aug 1;238(8): 881-888
(check this in PDF content)
41
Tsioufis C, Dimitriadis K, Taxiarchou E et al. Diverse associations of microalbuminuria with C-reactive protein, interleukin-18 and soluble CD 40 ligand in male essential hypertensivDimitriadis K. Chatzis D et al. Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in men with essential hypertension. Am J Cardiol 2005 Oct 1; 96 e subjects. Am J Hypertens 2006; 19 (5): 462- 466
(check this in PDF content)
42
Tsioufis C., Dimitriadis K. Chatzis D et al. Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in men with essential hypertension. Am J Cardiol 2005; 96 (7): 946-951
(check this in PDF content)
43
Юренев АП, Рязанов АС, Жукова НВ, Аракелянц АА. Микроальбуминурия: клиническое и прогностическое значение при артериальной гипертонии. Терапевтический архив 2003; (12): 81-83 Авторы заявляют об отсутствии конфликта
(check this in PDF content)